Skip to main content

Table 1 Frequency of the CHEK2 R95* germline mutation in the Norwegian population

From: Prevalence of the CHEK2 R95* germline mutation

Individuals/patients R95*-carriersan Wild-type n Total MAF
Non-cancer individuals 4 3744 3748 5.3 × 10−4
Cancer patients 8 7073 7081 5.6 × 10−4
 Breast cancer 4 1713 1717 1.2 × 10−3
 Prostate cancer 4 2497 2501 8.0 × 10−4
 Lung cancer 0 1331 1331 0
 Colorectal cancer 0 1532 1532 0
Total 12 10,817 10,829 5.5 × 10−4
  1. aAll R95* carriers were heterozygous